Contents

Meeting Information

[Name]

The 122nd Annual Meeting of the Japanese Dermatological Association

[Dates]

June 1(Thu.) - 4(Sun.), 2023

[Venue]

Pacifico Yokohama
1-1-1 MinatoMirai, Nishi-ku, Yokohama 220-0012, Japan

[Committee Members]

  • President: Shinichi Sato
  • Department of Dermatology, Faculty of Medicine, University of Tokyo
  • Secretary General: Ayumi Yoshizaki, M.D., Ph.D.

Registration

Registration fees are as follows
In principle, we accept only on-site registration. Please settle your registration fee by cash (Japanese Yen only) or credit card.

  • If you would like to online registration, please let us know by email until May 23, 2023. (JST)
    (westec_op1@jtb.com)
JDA Member JPY 20,000
Japanese Student/
Overseas Student/Resident*
JPY 15,000
Non-Member (Company member) JPY 40,000
Non-Member (Others) JPY 25,000
Accompanying Person** JPY 3,000

Students and Residents need to submit their identification.
Students including undergraduates and postgraduates are requested to submit a proof of their status such as a photocopy of a valid student ID card or a letter from the dean, the department head or the research director with their signature.
The Accompanying Persons' registration fee is available only to partners and/or family members of paid delegates registered to attend the Conference. It covers the only admission for Corporate Exhibition venue. Accompanying person cannot access to a lecture room.

Call for Abstracts

Submission period

From Thursday, November 10, 2022 to Tuesday, December 6, 2022 (tentative)
Tuesday, December 20, 2022 (tentative)
10 am on Monday, December 26, 2022 (tentative)
(Japan Standard Time)

Online abstract submission is now closed.

Abstract Submission Procedures

  • All abstracts must be submitted through the online abstract submission system.
  • Please see the following guidelines before proceeding to the abstract submission page. Click the button at the end of this page to submit.
  • For those who have difficulty accessing the online submission system on this website, please contact the secretariat office.

Requirements for Abstract Submission

Only one paper can be presented by the same author and/or presenter, although a presenter can be a coauthor of other papers.

[Encore abstract]

JDA annual meeting will not accept the abstract with exact same title and contents published before in other meetings and articles. JDA has this policy to avoid double publication as a fraud.
If you add a new data or information on the previous reports, we would consider to accept the abstract.

Guidelines for Writing Abstracts

[Presentation style]

We prepare sessions of "Oral Presentations in English" in our meeting on June 1, 2023. You can select your presentation type either of "Oral and Poster" or "Poster Only". The Local Organizing Committee will review the abstracts and decide their final presentation styles (oral and poster presentation or poster only presentation). If your abstract accepted as an oral and poster-presentation, you are kindly requested to present it orally on June 1, 2023 and also discussion it as a poster on June 2, PM or June 3,PM.
You could choose how to present orally depending on the circumstances, from at on site or online or prerecorded.
Basically, presenters are required to prepare both paper and digital poster. If it is difficult to come to Japan due to COVID-19, you are not required to prepare a paper poster.

If your abstract is not accepted as an oral presentation, you can present it poster only.
Poster discussion is open-ended and speakers should stand-by in front of the poster at the poster discussion time (June 2, PM or June 3, PM).
And poster presenters are requested to prepare their paper and digital poster.(same data)
(If it is difficult to come to Japan due to COVID-19, you are not required to prepare a paper poster.)

[Category]

Please choose from the following categories:

  1. Basic research
  2. Diagnosis
  3. Treatment
  4. Dermatopathology
  1. Dermatologic surgery
  2. Inflammatory disease
  3. Allergic disease
  4. Autoimmune disease
  1. Tumor
  2. Congenital disease
  3. Infectious disease
  4. Others

[Abstract Publication]

Your abstract will be published in the meeting program and abstract book.

[Restrictions]

  • Only abstracts submitted through the online abstract submission system will be considered.
  • Abstracts must be submitted in clear English with accurate grammar and spelling.
  • Please note that abstracts will be published as submitted, so please check carefully all names as well as spelling and grammar.

Abstract title must be 90 letters or less, including spaces.
Abstract body must be 800 letters or less, including spaces.
Up to 10 coauthors, including authors, and up to 10 affiliations may be registered.

Online Abstract Submission

Abstract Submission

  • Depending on the computer environment, there may be cases where the registrant is unable to register from the meeting web page. (e.g. Firewall is set to prevent intrusion) Please confirm your internet environment in advance.
  • It is mandatory that the registrant has an e-mail address that can be made through to him/her.
  • An e-mail will be generated automatically to inform the registrant that the abstract is registered. Please be extra careful not to mistype your e-mail address.
*If you do not receive the e-mail, the following may be the cause:

A. You can confirm your abstract from the "Confirmation & Correction" page.
- The e-mail address input was incorrect: Submission has successfully concluded. To avoid duplicated submission, do not submit more than twice. Please confirm and modify the e-mail address from the Confirmation & Correction page.

B. You cannot confirm your abstract from the "Confirmation & Correction" page.
- The submission process did not finish properly: Please submit again.

*Please do not use Gmail as much as possible.
Please note that those who have registered Gmail address may not receive emails from the abstract submission system.

  • Compatible browsers are Internet Explorer, Safari version 2.0.3 (417.9.2) or above, Firefox, Microsoft Edge and Google Chrome. Do not use other browsers.

Before Submission

  • Registered data will be published on the abstract book. There will be no proofreading by the secretariat office. Please be extra careful not to mistype your abstract.
  • Change in abstract, including coauthor information, will not be accepted after the deadline. Please confirm thoroughly before submission.

Password

Before you finish your registration, you are required to enter password. Password is case sensitive and must be 4 or more characters long. Do not use passwords used for hospital information systems and e-mails.

Data Entries

<Entering symbols, Greek Letters and other special characters>
Symbols and Greek Letters must be entered using the respective codes from the list of "Abstract Body" on the Registration site. (You may cut and paste from the list.)
Follow the instructions below for special characters. These are also available on the Registration site for you to cut and paste.

  • Superscripts: <SUP></SUP>
    Example: Na<SUP>+</SUP>=Na+
  • Subscripts: <SUB></SUB>
    Example: H<SUB>2</SUB>O=H2O
  • Italics: <I></I>
    Example: <I>c-fos</I>=c-fos
  • Bold: <B></B>
    Example: <B>AAA</B>=AAA
  • Underline: <U></U>
    Example: <U>BBB</U>=BBB
  • If you wish to use "<" (less than) or ">" (greater than) in your abstract (e.g. p<0.05), to distinguish special character codes "< > "explained above from single uses of "<" or ">", enter "&gt;" for ">" and "&lt;" for "<".
    Example: p&lt;0.05=p<0.05

Complete Registration

Please confirm the contents you have input before clicking the "Confirm to submit" button.
After submission, registration number (number in the 30000s) will be automatically generated. With the registration number being generated, the abstract submission process is concluded. You will receive a confirmation mail from the system. If you do not see your registration number in the web page, please be aware that the abstract has not been accepted yet.
Please note that the secretariat office will not answer any questions related to the passwords for security purposes.

Should you have any queries on the online registration system, please contact the secretariat office.

Correction

For adding correction to registered abstracts, use the "Confirmation and Correction" button. Before the due date, confirmation and correction can be made repeatedly by inputting the registration number and password.

Abstract Submission Procedures

Submission Periods

From Thursday, November 10, 2022 to Tuesday, December 6, 2022 (tentative)
Tuesday, December 20, 2022 (tentative)
10 am on Monday, December 26, 2022 (tentative)
(Japan Standard Time)

Online abstract submission is now closed.

  • The system will automatically close after the above date. Corrections, registrations and deleting of the abstracts will not be allowed after the deadline.

Click "Abstract Submission" button when submitting your abstract for the first time.

Evaluation

All abstracts will be reviewed and presentation styles (oral and digital poster presentation or digital poster presentation only) will be decided by the Local Organizing Committee.

Notification of Accepted Abstracts

First authors will be informed of the decision of the evaluation at the address given for correspondence by early February, 2023. At that time, you will be given full details of your presentation.

Travel grants available (For the participants on site only)

A limited number of travel grants will be awarded by the Local Organizing Committee for applicants, whose abstracts have been evaluated as outstanding.
Authors wishing to be considered for a travel grant should complete the abstract submission. The nominee must be first author (i.e. presenting author) of an abstract submitted, and should provide proof of their student's or training status with a certificate of the University resp. Head of Department.
Deadline for submission of Travel grants
You are required to send a proof of their student's or training status with a certificate of the
University resp. Head of Department by Tuesday, December 6, 2022
by Tuesday, December 20, 2022
(Japan Standard Time).

Program and Abstract

How to view the live streaming and digital poster

Abstract Acceptance

Please check your presentation style.
If your abstract has "conflict of interest (COI)", please mention it at the beginning of your presentation and specify at your poster.
For more information, please check the heading of "Presenter's Instruction" that is scheduled to be released on this website at a later date.

Oral Presentations

The time schedule is very tight. Please keep the allotted time strictly.
5 minutes for presentation and 2 minutes for discussion.
We will inform the oral presenters how to prepare your oral presentation data soon.

Posters Presentations

*All accepted abstracts need to prepare both the paper poster and the digital poster prior to the meeting.
  (If it is difficult to come to Japan due to COVID-19, you are not required to prepare a paper poster.)
*All posters must be prepared in English.

[Digital poster Registration Period]
From Tuesday, April 18, 2023 to noon Wednesday, May 17, 2023.(tentative)

All of the registered poster data will be freely viewable only for JDA member and participants available for your iPads (by app).
They can check the presentation data only during meeting. (From June 1 to June 4, 2023)
Please make sure to register your poster data in advance to the congress.

[Paper poster requirements]
Poster
  • Posters should be posted on the designated board space of 180cm height and 90cm width with the abstract number of your paper.
  • Title, Author's name, Affiliation should be prepared by yourself.
  • Poster mounting and removal hours are as follows:
    Mount posters:
    June 1(Thu.) 8:00-13:00
    Remove posters:
    June 4(Sun.)14:00-16:00
    *Posters should be up all the time during the congress.
  • The poster venue is located at Pacifico Yokohama, 1F Exhibition Hall A/B.
  • Abstract Numbers, pins and equipment necessary for mounting posters will be prepared by the secretariat at the venue.
  • Poster discussion is open-ended. Speakers should stand by in front of the poster at the poster discussion time.
    Abstract - Odd numbers
    June 1(Thu.) 18:30-19:50(tentative)
    Abstract - Even numbers
    June 2(Fri.) 18:30-19:30(tentative)
Submission Number Poster Number Oral Number Date of Oral Presentation Time of Oral Presentation Session theme of Oral Presentation Category of Poster
10019 EP11-1 - - - - Others
10035 EP5-1 - - - - Inflammatory disease
10040 EP10-1 E4-1 June 1(Thu.) 15:30-16:30 Oral Presentation in English 4 Infectious disease
10074 EP7-1 E3-2 June 1(Thu.) 14:30-15:30 Oral Presentation in English 3 Autoimmune disease
10082 EP7-4 - - - - Autoimmune disease
10108 EP2-1 - - - - Diagnosis
10123 EP8-1 E2-4 June 1(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
10140 EP8-2 E2-8 June 1(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
10142 EP7-5 E3-3 June 1(Thu.) 14:30-15:30 Oral Presentation in English 3 Autoimmune disease
10152 EP2-2 E1-4 June 1(Thu.) 9:00-10:00 Oral Presentation in English 1 Diagnosis
10162 EP7-6 E3-8 June 1(Thu.) 14:30-15:30 Oral Presentation in English 3 Autoimmune disease
10195 EP4-1 E2-3 June 1(Thu.) 10:00-11:00 Oral Presentation in English 2 Dermatologic surgery
10207 EP9-1 E4-2 June 1(Thu.) 15:30-16:30 Oral Presentation in English 4 Congenital disease
10208 EP8-3 - - - - Tumor
10209 EP7-7 E3-4 June 1(Thu.) 14:30-15:30 Oral Presentation in English 3 Autoimmune disease
10210 EP2-3 E1-6 June 1(Thu.) 9:00-10:00 Oral Presentation in English 1 Diagnosis
10212 EP10-2 E4-5 June 1(Thu.) 15:30-16:30 Oral Presentation in English 4 Infectious disease
10242 EP3-1 E1-7 June 1(Thu.) 9:00-10:00 Oral Presentation in English 1 Treatment
10246 EP5-2 E3-1 June 1(Thu.) 14:30-15:30 Oral Presentation in English 3 Inflammatory disease
10257 EP8-4 - - - - Tumor
10267 EP2-4 E1-5 June 1(Thu.) 9:00-10:00 Oral Presentation in English 1 Diagnosis
10319 EP2-5 E1-1 June 1(Thu.) 9:00-10:00 Oral Presentation in English 1 Diagnosis
10332 EP7-8 E3-5 June 1(Thu.) 14:30-15:30 Oral Presentation in English 3 Autoimmune disease
10336 EP7-9 E3-7 June 1(Thu.) 14:30-15:30 Oral Presentation in English 3 Autoimmune disease
10353 EP5-3 - - - - Inflammatory disease
10355 EP1-1 E1-3 June 1(Thu.) 9:00-10:00 Oral Presentation in English 1 Basic research
10382 EP7-10 - - - - Autoimmune disease
10386 EP5-4 - - - - Inflammatory disease
10398 EP8-5 E2-6 June 1(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
10417 EP8-6 E2-5 June 1(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
10428 EP8-7 E2-1 June 1(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
10430 EP6-1 - - - - Allergic disease
10433 EP1-2 E1-2 June 1(Thu.) 9:00-10:00 Oral Presentation in English 1 Basic research
10442 EP7-11 - - - - Autoimmune disease
30002 EP3-2 E1-8 June 1(Thu.) 9:00-10:00 Oral Presentation in English 1 Treatment
30003 EP4-2 - - - - Dermatologic surgery
30004 EP11-2 E4-4 June 1(Thu.) 15:30-16:30 Oral Presentation in English 4 Others
30005 EP5-5 - - - - Inflammatory disease
30007 EP5-6 - - - - Inflammatory disease
30008 EP8-8 E2-7 June 1(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
30009 EP5-7 - - - - Inflammatory disease
30010 EP7-2 - - - - Autoimmune disease
30011 EP11-3 E4-8 June 1(Thu.) 15:30-16:30 Oral Presentation in English 4 Others
30012 EP5-8 E3-6 June 1(Thu.) 14:30-15:30 Oral Presentation in English 3 Inflammatory disease
30013 EP5-9 - - - - Inflammatory disease
30014 EP8-9 - - - - Tumor
30015 EP10-3 - - - - Infectious disease
30016 EP10-4 - - - - Infectious disease
30017 EP10-5 - - - - Infectious disease
30018 EP10-6 - - - - Infectious disease
30019 EP7-3 - - - - Autoimmune disease
30020 EP10-7 E4-3 June 1(Thu.) 15:30-16:30 Oral Presentation in English 4 Infectious disease
30021 EP3-3 - - - - Treatment
30022 EP6-2 - - - - Allergic disease
30023 EP10-8 E4-6 June 1(Thu.) 15:30-16:30 Oral Presentation in English 4 Infectious disease
30024 EP10-9 E4-7 June 1(Thu.) 15:30-16:30 Oral Presentation in English 4 Infectious disease
30025 EP8-10 E2-2 June 1(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
30026 EP10-10 - - - - Infectious disease
30028 EP10-11 - - - - Infectious disease
30029 EP3-4 - - - - Treatment
30030 EP10-12 - - - - Infectious disease
30031 EP10-13 - - - - Infectious disease
30032 EP10-14 - - - - Infectious disease
30027 EP1-3 - - - - Basic research
見つかりませんでした

Contact us

Secretariat Office of
The 122nd Annual Meeting of the Japanese Dermatological Association
c/o The Japanese Dermatological Association
FAX : +81-3-3812-6790
E-mail : jda2023@dermatol.or.jp